GeneDx Holdings (WGS) Net Cash Flow Growth (3y) (2023 - 2026)
GeneDx Holdings (WGS) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -10.07% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.97% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 144.76% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 41.14% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 29.81% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -26.81% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 14.18% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 4.49% |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn | -28.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.96% |
| Dec 31, 2025 | 28.74% |
| Sep 30, 2025 | 30.73% |
| Jun 30, 2025 | -14.86% |
| Mar 31, 2025 | 29.45% |
| Dec 31, 2024 | 34.81% |
| Sep 30, 2024 | -83.76% |
| Jun 30, 2024 | 4.96% |
| Mar 31, 2024 | 31.35% |
| Dec 31, 2023 | 124.47% |
| Sep 30, 2023 | -297.41% |